HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical trials are designed and executed. At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, HopeAI ...

Gross profit (GAAP) was $339,000 for the six months ended June 30, 2025, down from $799,000 in 2024, yielding a gross margin of 28% versus 46% for the six months ended June 30 in 2025 and 2024, ...